Skip to content
Stock Boards
Toggle navigation
Mailbox
Favorites
Boards
All Boards
The Hangout
NASDAQ
NYSE
OTC Markets
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Search
Search Type
Board
Post
Member
Go!
RSS
Show Info
GNPX
Genprex Inc.
Mod:
KUBA75
Last Post:
10/15/24
Followers:
1
Posts Today:
0
Views Today:
35
GNPX
GNPX Stock Quote & Tools
Company Profile
Buy Rating
Time & Sales
News
Filings
Financials
GNPX Stock Message Board Discussion
New Post
Follow
Create New Post
View All Posts
Follow Board
Banned
Lee Adams
10/15/2024 9:52:25 AM
Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1
Lee Adams
10/10/2024 9:37:06 AM
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy
Lee Adams
10/07/2024 9:38:44 AM
$GNPX News: Genprex Collaborators to Present Positive Preclinical Data on Reqorsa Gene Therapy
Lee Adams
09/09/2024 9:35:58 AM
$GNPX News: Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa
Lee Adams
09/04/2024 9:42:22 AM
$GNPX News: Genprex Announces Plans to Launch Separate Company to Focus on the Development of
Lee Adams
09/03/2024 10:10:05 AM
$GNPX News: Genprex to Present and Participate at Upcoming September Investor and Industry
trooperstocks
05/30/2024 9:10:09 AM
$GNPX News: Genprex to Present at the 2024 BIO International Convention PR Newswire Thu,
Lee Adams
05/14/2024 10:27:39 AM
$GNPX News: Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene
Lee Adams
05/13/2024 2:20:58 PM
$GNPX News: Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board
NetworkNewsWire
04/02/2024 5:01:34 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting
NetworkNewsWire
03/25/2024 4:29:05 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering
NetworkNewsWire
03/20/2024 5:25:50 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct
NetworkNewsWire
03/19/2024 4:51:25 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering
NetworkNewsWire
02/07/2024 3:04:34 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Announces New Research Collaborations, Expansion
NetworkNewsWire
02/06/2024 3:05:52 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Announces Participation at This Months BIO CEO
NetworkNewsWire
02/05/2024 4:13:07 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study
whytestocks
01/05/2024 3:35:47 PM
$GNPX News Article - Genprex Provides Business Update and Outlook for 2024
NetworkNewsWire
11/22/2023 3:50:38 PM
Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA,
NetworkNewsWire
11/01/2023 4:23:14 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) to Present at BIO-Europe 2023 Genprex
NetworkNewsWire
10/04/2023 5:23:44 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) to Unveil Encouraging Data on REQORSA(R) for
whytestocks
10/04/2023 12:05:52 PM
$GNPX News Article - Genprex to Present Data on the Use of REQORSA for the Treatment of Lung
NetworkNewsWire
09/20/2023 4:05:25 PM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
NetworkNewsWire
09/20/2023 3:51:10 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Building Protection and Powerful IP Portfolio
NetworkNewsWire
09/15/2023 4:43:16 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of
NetworkNewsWire
09/07/2023 4:13:17 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright
NetworkNewsWire
09/05/2023 4:23:43 PM
Genprex Inc. (NASDAQ: GNPX) Obtains New License for Novel Diabetes Gene Therapy Pipeline
whytestocks
09/05/2023 1:50:50 PM
$GNPX News Article - Genprex Inc. (NASDAQ: GNPX) Obtains New License for Novel Diabetes Gene
NetworkNewsWire
09/01/2023 4:14:09 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in Some of the Most
NetworkNewsWire
08/30/2023 4:31:31 PM
Genprex Inc. (NASDAQ: GNPX) Celebrates Receipt of Orphan Drug Designation, Third Fast Track
NetworkNewsWire
08/22/2023 5:15:22 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Appoints Regulatory Expert as It Drives
whytestocks
08/22/2023 12:05:48 PM
$GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Appoints Regulatory Expert as
NetworkNewsWire
08/10/2023 3:33:45 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Granted FDA Orphan Drug Designation for
whytestocks
08/10/2023 3:25:46 PM
$GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Granted FDA Orphan Drug
whytestocks
08/10/2023 2:35:47 PM
$GNPX News Article - Genprex Granted FDA Orphan Drug Designation (ODD) for REQORSA Immunogene
NetworkNewsWire
08/04/2023 5:28:07 PM
NetworkNewsBreaks Genprex Inc.s (NASDAQ: GNPX) Third Fast Track Designation Validates
NetworkNewsWire
07/28/2023 4:32:06 PM
Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in
whytestocks
07/28/2023 1:20:49 PM
$GNPX News Article - Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R)
NetworkNewsWire
07/19/2023 5:14:33 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering
NetworkNewsWire
07/18/2023 4:42:44 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with
whytestocks
07/18/2023 12:25:47 PM
$GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License
NetworkNewsWire
07/17/2023 4:22:00 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Positioned to Expand Its Clinical Pipeline
NetworkNewsWire
07/10/2023 5:01:45 PM
Genprex Inc. (NASDAQ: GNPX) Reports Positive Results from its Phase 1 Acclaim-1 Clinical Trial;
NetworkNewsWire
07/06/2023 4:16:11 PM
Genprex, Inc. (NASDAQ: GNPX) Receives Third Fast Track Designation for REQORSA(R), Setting Stage
NetworkNewsWire
07/06/2023 4:10:29 PM
NetworkNewsBreaks Genprex Inc.s (NASDAQ: GNPX) Unique Treatment Paradigm Featured in
whytestocks
06/28/2023 2:25:46 PM
$GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Receives Fast Track
NetworkNewsWire
06/23/2023 4:19:10 PM
Genprex Inc. (NASDAQ: GNPX) CMO Discusses Recent Company Announcements in Bell2Bell Podcast
NetworkNewsWire
06/20/2023 4:20:04 PM
Genprex Inc. (NASDAQ: GNPX) CMO Video Discusses Advances in Companys Fight Against Tumors
NetworkNewsWire
06/16/2023 5:04:34 PM
NetworkNewsBreaks Genprex Inc.s (NASDAQ: GNPX) Flagship Candidate Could Potentially Reshape
NetworkNewsWire
06/14/2023 4:55:01 PM
Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating
NetworkNewsWire
06/07/2023 4:55:34 PM
NetworkNewsBreaks Genprex Inc. (NASDAQ: GNPX) Eyes Broad-Based Application Potential of
Older
